the control siRNA used was described elsewhere 29 .
The global shortening of messenger RNAs through alternative polyadenylation (APA) that occurs during enhanced cellular proliferation represents an important, yet poorly understood mechanism of regulated gene expression 1, 2 . The 39 untranslated region (UTR) truncation of growth-promoting mRNA transcripts that relieves intrinsic microRNA-and AU-rich-element-mediated repression has been observed to correlate with cellular transformation 3 ; however, the importance to tumorigenicity of RNA 39-end-processing factors that potentially govern APA is unknown. Here we identify CFIm25 as a broad repressor of proximal poly(A) site usage that, when depleted, increases cell proliferation. Applying a regression model on standard RNA-sequencing data for novel APA events, we identified at least 1,450 genes with shortened 39 UTRs after CFIm25 knockdown, representing 11% of significantly expressed mRNAs in human cells. Marked increases in the expression of several known oncogenes, including cyclin D1, are observed as a consequence of CFIm25 depletion. Importantly, we identified a subset of CFIm25-regulated APA genes with shortened 39 UTRs in glioblastoma tumours that have reduced CFIm25 expression. Downregulation of CFIm25 expression in glioblastoma cells enhances their tumorigenic properties and increases tumour size, whereas CFIm25 overexpression reduces these properties and inhibits tumour growth. These findings identify a pivotal role of CFIm25 in governing APA and reveal a previously unknown connection between CFIm25 and glioblastoma tumorigenicity.
Recently, it has become increasingly clear that mRNA 39-end formation is subject to dynamic regulation under diverse physiological conditions [2] [3] [4] [5] . Over 50% of human genes have multiple polyadenylation signals, thereby increasing the potential diversity in mRNA transcript length 6 . The formation of mRNA transcripts using these distinct poly(A) sites (PASs) is carried out by APA, with the most common form involving differential use of alternative PASs located within the same terminal exon (reviewed in ref. 7) . Processing at the PAS most proximal to the stop codon (pPAS) removes negative regulatory elements that reduce mRNA stability or impair translation efficiency, such as AUrich elements (AREs) 8 and microRNA (miRNA) targeting sites 9, 10 . It has been reported that both rapidly proliferating cells 1,2 and transformed cells 3, 11 preferentially express mRNAs with shortened 39 UTRs. Despite these observations, the mechanisms that control the extensive distalto-proximal PAS switch observed in proliferative and/or transformed cells, the relationship between cause and effect, and the critical target genes subject to this regulation, are not well characterized.
To measure relative changes in endogenous APA events, we devised a quantitative polymerase chain reaction after reverse transcription (qRT-PCR) assay to monitor the transcript-specific use of the distal PAS (dPAS) while normalizing for total mRNA levels for three test transcripts, cyclin D1 (CCND1), DICER1 and TIMP2, known to undergo APA 3, 12 . Using this approach, we readily detected appreciable usage of dPASs for all three genes in HeLa cells (Extended Data Fig. 1 ). This was somewhat surprising given their highly transformed state, but is consistent with previous reports that not all transformed cells tested exhibit appreciable 39 UTR shortening 1, 3 . Previous studies implicate multiple members of the cleavage and polyadenylation (CPA) machinery as potentially regulating poly(A) site selection [12] [13] [14] [15] . To test the relative contribution of these factors to the APA of the three test genes, we used systematic RNA interference (RNAi) ( Fig. 1a-c) . We observed only small changes in the relative use of the dPAS after knockdown of members of the cleavage and polyadenylation specificity factor (CPSF), cleavage stimulation factor (CSTF) and cleavage factor IIm (CFIIm) complexes ( Fig. 1d-f ). By contrast, we detected significant reduction in dPAS usage after knockdown of the members of the CFIm complex. These results are consistent with a recent report that CFIm68 depletion decreases 39 UTR length 14 ; however, the most notable PAS switching was found to occur after knockdown of CFIm25. We therefore focused all further analyses on CFIm25.
Traditional methods of global PAS profiling use mRNA partitioning and digestion to sequence poly(A) junctions within messages 1, 16, 17 . To identify global targets of CFIm25 with a more streamlined approach requiring less sample manipulation, we performed high-depth (.3 3 10 8 reads) RNA sequencing (RNA-seq) after knocking down CFIm25 in parallel with a control knockdown. We determined that 23% of RNA-seq reads can be uniquely mapped to 39 UTRs of expressed genes leading to approximately 200-fold sequence coverage (Extended Data Fig. 2a, b ). We first analysed the three test genes and observed markedly reduced read density within the 39 UTRs in response to CFIm25 depletion ( Fig. 2a ). These results not only confirm our qRT-PCR findings that HeLa cells robustly use the dPAS for all three test genes under basal conditions but also demonstrate that considerable 39 UTR shortening induced by CFIm25 knockdown is readily visualized by analysing the read density of RNA-seq data.
On the basis of this promising observation, we applied a novel bioinformatics algorithm termed 'dynamic analysis of alternative polyadenylation from RNA-seq' (DaPars; see Methods) for the de novo identification of all instances of 39 UTR alterations between control and CFIm25 knockdown cells, regardless of a pre-annotated pPAS within each RefSeq transcript. DaPars uses a linear regression model to identify the exact location of this novel proximal 39 UTR as the optimal fitting point ( Fig. 2b , red point) as well as the abundance of both novel and annotated UTRs. The degree of difference of 39 UTR usage between the samples was then quantified as a change in percentage dPAS usage index (DPDUI), which is capable of identifying lengthening (positive index) or shortening (negative index) within the 39 UTR. When applied to the 12,273 RefSeq transcripts whose average terminal exon sequence coverage is more than 30-fold, DaPars identified 1,453 transcripts possessing a significant, reproducible shift in 39 UTR usage in response to CFIm25 depletion ( Fig. 2c and Extended Data Fig. 2c, d) .
Notably, among this group of transcripts, 1,450 are shifted to pPAS usage in CFIm25 knockdown cells. We found a significant enrichment of the CFIm25 UGUA binding motif and previously reported CFIm25 iCLIP sequence tags 14 within 39 UTRs that shortened after CFIm25 knockdown relative to transcripts exhibiting no length change (Extended Data Fig. 3 ).
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Moreover, we determined that 70% of transcripts whose 39 UTR is shortened after CFIm25 knockdown use a pPAS within the first one-third of their 39 UTR. By contrast, only 29% of multi-PAS transcripts that did not alter 39 UTR length in response to CFIm25 have an annotated pPAS in the first third of their 39 UTR. This demonstrates that CFIm25 APA targets are enriched with pPASs positioned close to the stop codon to maximize their degree of 39 UTR shortening. Collectively, these results clearly indicate that the function of CFIm25 is to broadly repress proximal poly(A) site choice, and consequently, the shortening of 39 UTR length is considerable for the majority of CFIm25-regulated transcripts upon its depletion. One potential consequence of 39 UTR shortening in CFIm25 knockdown is the loss of miRNA-binding sites and/or AREs, resulting in truncated mRNA transcripts that evade negative regulation. Although the correlation between transcript expression change and DPDUI was modest (Pearson correlation 5 20.25), it does reveal that transcripts with shorter 39 UTR in CFIm25 knockdown cells have overall higher expression levels (Fig. 2d ). We observed that 64% of transcripts with shortened 39 UTRs exhibited significantly increased steady-state levels, 34% were unchanged, and only 2% were significantly reduced (Extended Data Fig. 4 ). We have also organized the list of CFIm25-regulated genes with respect to their DPDUI score, change in relative levels of transcript, and predicted numbers of ARE motifs and miRNA target sites lost after APA (Supplementary Table 1 ) and observed that gene expression positively correlates with the number of lost ARE motifs and miRNA target sites (Extended Data Fig. 5 ). Several examples of novel genes whose APA is regulated by CFIm25 are shown in Fig. 2e and it is important to note that not all long 39 UTRs were observed to shorten in response to CFIm25 knockdown, indicating that the CFIm complex regulates many, but not all genes capable of APA (Fig. 2f ). Collectively, these data demonstrate the power and ease of the DaPars algorithm to identify APA within standard RNAseq, and indicate that the major form of CFIm25 regulation is to repress pPAS choice at a global level.
To validate the DPDUI results, we created qRT-PCR amplicons to monitor dPAS usage of six genes whose 39 UTRs were found to be shortened after CFIm25 knockdown and two that were not altered. Using these amplicons, we analysed RNA isolated from cells effectively depleted of CFIm25 using two independent short interfering RNAs (siRNAs) (Fig. 3a, inset) , and observed high congruence between qRT-PCR results and those obtained using RNA-seq and DPDUI (Fig. 3a, graph) . To test formally for the presence of de-repressed protein expression from mRNAs with shortened 39 UTRs, we measured their levels in lysates from knockdown cells (Fig. 3b ). We observed considerable increases in protein levels of CFIm25 target genes, including several that have a well-documented role in tumour growth, such as cyclin D1, glutaminase and methyl-CpG-binding protein 2 (MECP2) [18] [19] [20] [21] [22] . It is worth noting that the 39 UTR of each of these genes has been shown to be subject to miRNA-mediated inhibition [23] [24] [25] . Consistent with this observation, we also noted enhanced cellular proliferation in response to knockdown of CFIm25 relative to control knockdown in HeLa cells (Fig. 3c ). Finally, to determine whether the 39 UTR is sufficient to elicit translational derepression of a heterologous protein in response to CFIm25 knockdown, we used reporters with the SMOC1 39 UTR cloned downstream of luciferase or the GAPDH 39 UTR, which was not found to alter its poly(A) site usage. We observed that only the luciferase activity specifically resulting from the luciferase-SMOC1 reporter was increased in response to knockdown of CFIm25 (Fig. 3d) , supporting the idea that the increased expression of endogenous SMOC1 protein when CFIm25 is depleted is mediated through its 39 UTR.
The collective observations that CFIm25 depletion leads to broad 39 UTR shortening, enhanced expression of growth promoting genes and increased cell proliferation support the hypothesis that CFIm25 is a novel anti-proliferative gene whose levels may be reduced in human cancers. We focused our analysis on glioblastoma, as recent reports indicate that brain tissue possesses the longest 39 UTRs 26, 27 . We reasoned that tumours derived from these cells might be more sensitive to changes in CFIm25 levels than other cancers. To test this prediction, we downloaded archived patient RNA-seq data from The Cancer Genome Atlas (TCGA), stratified it according to CFIm25 expression, and analysed it using DaPars. Indeed, following the same cut-offs in our HeLa RNA-seq 39 UTR analysis, we identified 60 genes with altered 39 UTRs, with 59 of those experiencing shortening in glioblastoma expressing lower levels of CFIm25 ( Fig. 4a and Supplementary Table 2 ). Among those genes, a significant number of events (24 genes; P 5 2.2 3 10 212 by hypergeometric testing) were also shortened in CFIm25 knockdown HeLa cells and this percentage of overlap increased markedly to 86% as the DPDUI cut-off increased from 0.2 to 0.4 (Extended Data Fig. 6 ). Two representative examples of genes, FOS-related antigen 2 (FRA2; also known as FOSL2) and MECP2, with shortened 39 UTRs in low CFIm25-expressing glioblastoma tumours is shown in Fig. 4b , demonstrating a compelling similarity between the patient samples and HeLa cells before and after CFIm25 knockdown. Overexpression of either of these genes has been shown to enhance cell proliferation 18, 28 .
To test formally whether altering CFIm25 expression can modulate glioblastoma tumorigenic properties, we screened a panel of glioblastoma cell lines and observed that U251 cells naturally express lower levels of CFIm25 compared with LN229 cells (Fig. 4c ). To raise CFIm25 levels in U251 cells, we created cell lines stably expressing either Myc-tagged CFIm25 or green fluorescent protein (GFP) as a control. In parallel, we used RNAi to reduce CFIm25 levels in LN229 cells (Fig. 4c ). We observed a significant reduction in anchorage-dependent growth and cellular invasion in U251 cells overexpressing CFIm25 compared with the GFP control, whereas reducing CFIm25 in LN229 cells caused an increase in both of these properties (Extended Data Fig. 7) . To determine if the altered in vitro properties of glioblastoma cells affected tumour growth kinetics in vivo, we used a subcutaneous xenograft model. Increased expression of CFIm25 in U251 cells resulted in a marked reduction in tumour growth and decreased tumour cell proliferation ( Fig. 4d and Extended Data Fig. 8 ). By contrast, depletion of CFIm25 in LN229 cells caused a profound increase in tumour size ( Fig. 4e and Extended
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Con. Data Fig. 9 ). Collectively, these results uncover a tumour suppressive property of CFIm25 in glioblastoma that is probably mediated through its broad repression of APA-dependent mRNA 39 UTR shortening.
We identified CFIm25 among 15 cleavage and polyadenylation factors as a key factor that broadly regulates APA. Importantly, the data presented here also extend our understanding of APA in regulated gene expression through the demonstration that extensive shortening of 39 UTRs causally leads to enhanced cellular proliferation and tumorigenicity, probably through the upregulation of growth promoting factors, such as cyclin D1. These results indicate the importance of 39 UTR usage in cell growth control and underscore the need for further research into the mechanism and regulation of APA and its potential links to other human diseases.
METHODS SUMMARY
Human cell lines used were cultured using standard techniques. RNAi and western blot experiments were conducted as described previously 29 . For luciferase experiments, one day after the second siRNA hit, cells were transfected with 39 UTR Renilla luciferase plasmids and activity was assayed after 24 h. Total RNA for pRT-PCR was reverse transcribed using MMLV-RT (Invitrogen). qRT-PCR reactions were performed using SYBRGREEN (Fermentas). Duplicate control and CFIm25 knockdown samples were sequenced by HiSeq 2000. RNA-seq reads were aligned (hg19) using TopHat 2.0.10 30 . All the TCGA glioblastoma RNA-seq BAM files were downloaded from the UCSC Cancer Genomics Hub (https://cghub.ucsc.edu/). DaPars was used to identify differential 39 UTR usage from RNA-seq (Z.X. et al., unpublished observations; https://code.google.com/p/dapars). For tumour xenografts, U251 cells were stably transfected with GFP or CFIm25 plasmids. LN229 cells were transfected with lentivirus expressing CFIm25 shRNA. After subcutaneous injection of cell lines into nude mice, glioblastoma tumour size was monitored and tumours were removed and histologically analysed.
Online Content Any additional Methods, Extended Data display items and Source Data are available in the online version of the paper; references unique to these sections appear only in the online paper. To quantify the relative PAS usage, we defined the percentage of dPAS usage for each sample as PDUI index. The greater the PDUI is, the more the dPAS of a transcript is used and vice versa. DPDUI. We used the following three criteria to detect the most significant shifted 39 UTR events: First, given the expression levels of short and long 39 UTRs in two samples in each condition, we compute the significance of the difference of mean PDUIs using Fisher's exact test, which is further adjusted by Benjamini-Hochberg (BH) procedure to control the FDR at a level of 5%. Second, the absolute difference of mean PDUIs must be no less than 0.2. Third, the absolute log 2 ratio (fold change) of mean PDUIs must be no less than 1. To avoid false positive estimation on low coverage transcripts, we required that there be more than 30-fold coverage on the 39 UTR region of both samples. For genes with multiple annotated PASs, we only kept the one with the greatest absolute DPDUI value. Last, we identified 1,453 transcripts possessing a significant shift in 39 UTR usage in response to CFIm25 knockdown, the vast majority of which have shortened 39 UTRs in CFIm25 knockdown. Bioinformatic analyses of 39 UTR shortening. As miRNA binding sites and other regulatory sequences such as AREs reside in 39 UTRs 33,34 , APA has an important role in mRNA stability, translation and translocation. Indeed, it has been reported that shorter 39 UTRs produce higher levels of protein 3 . To elucidate the consequences of 39 UTR shortening, we provided the numbers of lost ARE motifs and miRNA binding sites due to the 39 UTR shortening for the transcripts shifting to proximal 39 UTR usage in CFIm25 knockdown cells (Supplementary Table 1 ). The ARE is one of the most prominent cis-acting regulatory elements found in 39 UTRs to target mRNAs for rapid degradation 35 . The eight different consensus ARE motifs, including the plain AUUUA pentamer, were retrieved from the ARE site database 35 . miRNA-mRNA binding information was based on miRNA target prediction database TargetScanHuman version 6.2 [36] [37] [38] . To limit the miRNA to high-confidence sites, we required the probability of the preferentially conserved targeting (PCT) score to be more than 0 for all highly conserved miRNA families 38 . Differentially expressed gene expression analysis. With two replicates in each group, we used edgeR 39 to call differentially expressed genes with FDR , 0.05. To better quantify gene expression with shorter 39 UTRs, we counted reads based on the coding regions of each transcript. Cell culture and cell counts. All the cell lines used (HeLa, U251 and LN229) were cultured in DMEM supplemented with 10% FBS (11% penicillin and streptomycin) in a 5% CO 2 incubator at 37 uC. Cell counts were done using a standard hemacytometer. siRNA and western blot assays. Both siRNA transfection and western blot analysis were performed as previously described 29 . The siRNA was purchased from Sigma and all the siRNAs used are shown below. After transfection, cells were harvested for mRNA extraction, western blotting or Matrigel assay. To detect 39-end-processing factors by western blotting, the following primary antibodies from Bethyl Laboratories were used: CPSF160, CPSF100, CPSF73, CPSF30, FIP1, CSTF77, CSTF64t, CSTF50, CFIm68 and CFIm59. Other antibodies used include CFIm25 (PTGlabs), CSTF64 and CFIIm PCF11, and Symplekin (Sigma and CFIIm CLP1 (Epitomics). Additional antibodies include VMA21, GLS, ACER3 and GSK-3b (PTGlabs); cyclin D1 (Cell Signaling); and SMOC1 and tubulin (Abcam). siRNA sequences. We used the following siRNA sequences. CPSF160 si1: 59-GC UUUAAGAAGGUCCCUCA; si2: 59-CUUACCACGUGGAGUCUAA; CPSF100 si1: 59-CUCAACUUCUUGAUCAGAU; si2: 59-GGAUAGAUGGUGUCUUAG Extended Data Figure 1 | Design and optimization of the qRT-PCR assay to monitor APA of three test genes. a, Schematic denotes the relative location of the common and distal primer annealing sites in each test gene and the approximate locations of the annotated proximal and distal poly(A) sites, depicted as pPAS and dPAS, respectively. The numbers demarcate where the 39 UTR starts and ends according to ENSEMBL. b, Ethidium-stained agarose gel of RT-PCR products of equal cycle number from the different amplicons using HeLa cell mRNA. c, Both the common and distal cyclin D1 amplicons were cloned into the same pcDNA3 plasmid in tandem. Three dilutions of each plasmid were made and amplified individually with each amplicon in triplicate. The two lines on the graph depict the amplification curve for the common and distal amplicons. The expectation is that identical cycle threshold (CT) values should be attained for each, given that the PCR reactions were conducted using identical amounts of starting material. The average of three individual experiments is shown for each dilution and the average CT deviation of either amplicon at all of the dilutions was calculated as a correction factor. d, The experiment shown in c was repeated for DICER1 and TIMP2 to determine their respective correction factors, which was then applied to experiments shown in Fig. 1 .
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